Skip to main content
. 2018 Sep 12;10:117. doi: 10.1186/s13148-018-0549-1

Fig. 2.

Fig. 2

Potential of HDAC4-based therapy for ischemic stroke. Adenovirus- or adeno-associated virus-mediated HDAC4 overexpression and microRNA-based upregulation of HDAC4 have the potential to be translated into the clinic for ischemic stroke treatment. The therapeutic potential of HDAC4-modified stem cells remains elusive